Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution

References

• Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007; 82: 463–72
   PubMed Web of Science ®Google Scholar
• Jansen J, Thompson JM, Dugan MJ, Nolan P, Wiemann MC, Birhiray R. Peripheral blood progenitor cell transplantation. Therapeutic Apher. 2002; 6: 5–14
   PubMedGoogle Scholar
• Shpall EJ, Jones RB, Franklin WA, Archer PG, Curiel T, Bitter M, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34+ peripheral blood progenitors and growth factors on engraftment. J Clin Oncol. 1994; 12: 28–36
   PubMed Web of Science ®Google Scholar
• Rowley SD, MacLeod B, Heimfeld S, Holmberg L, Bensinger WI. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. Cytotherapy. 1999; 1: 311–17
   PubMed Web of Science ®Google Scholar
• Rowley SD, Feng Z, Holmberg L, Heimfeld S. Post-thaw removal of dimethysulfoxide does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy. 1999; 6: 439–46
   Google Scholar
• Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, Bensinger WI. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide versus dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant. 2003; 31: 1043–51
   PubMed Web of Science ®Google Scholar
• Reddy RL. Mobilization and collection of peripheral blood progenitor cells for transplantation. Transfus Apher Sci. 2005; 32: 63–72
   Google Scholar
• Barrett J. Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment. Curr Opin Immunol. 2006; 18: 592–8
   PubMed Web of Science ®Google Scholar
• Sartor M, Antonenas V, Garvin F, Webb M, Bradstock KF. Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products. Bone Marrow Trans. 2005; 36: 199–204
   PubMed Web of Science ®Google Scholar
• Frey NV, Lazarus HM, Goldstein SC. Has allogeneic stem cell cryopreservation been given the ‘cold shoulder’? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation. Bone Marrow Trans. 2006; 38: 399–405
   PubMed Web of Science ®Google Scholar
• Stylianou J, Vowels M, Hadfield K. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB. Cytotherapy. 2006; 8: 57–61
   PubMed Web of Science ®Google Scholar
• Parkins MD, Bahlis N, Brown C, Savoie L, Chaudrey A, Russell JA. Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation. Bone Marrow Trans. 2006; 38: 609–14
   Google Scholar
• Mazur P. Freezing and low-temperature storage of freezing of living cells: mechanisms and implications. Am J Physiol. 1984; 247: C125–42
   PubMed Web of Science ®Google Scholar
• Baust JG. Biology of cell survival in the cold: the basis for biopreservation of tissues and organs. Advances in Biopreservation, JG Baust, JM Baust. Taylor and Francis, Florida 2007; 1–14
   Google Scholar
• Taylor MJ. Biology of cell survival in the cold: the basis for biopreservation of tissues and organs. Advances in Biopreservation, JG Baust, JM Baust. Taylor and Francis, Florida 2007; 15–62
   Google Scholar
• Van Buskirk RG, Snyder KK, Baust JG, Mathew AJ, Baust JM. Cryopreservation: it's not just about cell yield. BioProcess Intl. 2005; 3: 64–72
   Google Scholar
• Baust JM, Van Buskirk RG, Baust JG. Modulation of the cryopreservation cap: elevated survival with reduced dimethyl sulfoxide concentration. Cryobiology. 2002; 45: 97–108
   PubMed Web of Science ®Google Scholar
• Liseth K, Abrahamsen JF, Bjorsvik S, Grottebo K, Bruserod O. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Cytotherapy. 2005; 7: 328–33
   PubMed Web of Science ®Google Scholar
• Hubel K, Gaviria JM, Rodger E, Price TH, Dale DC, Liles WC. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor. Transfusion 2005; 45: 1876–89
   PubMed Web of Science ®Google Scholar
• Yang H, Acker JP, Cabuhat M, Letcher B, Larratt L, McGann LE. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Bone Marrow Trans. 2005; 35: 881–7
   PubMedGoogle Scholar
• Takahashi T, Inada S, Pommier CG, O'Shea JJ, Brown EJ. Osmotic stress and the freeze–thaw cycle cause shedding of Fc and C3b receptors by human polymorphonuclear leukocytes. J Immunol. 1985; 134: 4062–8
   Google Scholar
• Armitage J, Mazur P. Osmotic tolerance of human granulocytes. Am J Physiol Cell Physiol. 1984; 247: C373–81
   PubMed Web of Science ®Google Scholar